Stay updated on DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Sign up to get notified when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.

Latest updates to the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page
- Check4 days agoChange DetectedThe page no longer lists Type 2 diabetes as the study condition. It also removes the related topics subsection, including the MedlinePlus Genetics link.SummaryDifference0.1%

- Check11 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, indicating a minor update to the page version. This change does not modify any content or data on the page.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedSite revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check54 days agoChange DetectedPage revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check75 days agoChange DetectedStatus updated to Completed with new dates; the previous 'Active, not recruiting' designation was removed.SummaryDifference0.4%

Stay in the know with updates to DECIDE Clinical Trial: Dapagliflozin vs. Standard Care
Enter your email address, and we'll notify you when there's something new on the DECIDE Clinical Trial: Dapagliflozin vs. Standard Care page.